Pain Medicine (Physical Medicine & Rehabilitation) Physician - 2081P2900X
Customize your policy alerts
Sign up for Pain Medicine (Physical Medicine & Rehabilitation) Physician - 2081P2900X policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
A physician who provides a high level of care, either as a primary physician or consultant, for patients experiencing problems with acute, chronic or cancer pain in both hospital and ambulatory settings. Patient care needs may also be coordinated with other specialists.
| Field | Value |
|---|---|
| Code | 2081P2900X |
| Grouping | Allopathic & Osteopathic Physicians |
| Classification | Physical Medicine & Rehabilitation |
| Specialization | Pain Medicine |
| Category | Individual |
NPI Registrations
5.7K NPIs are registered under this taxonomy code nationwide.
The table below splits that total by NPI type — Type 1 covers individual practitioners, Type 2 covers organizations and facilities — followed by the five states with the most NPIs registered under this taxonomy code.
Medicare: Top Billing Codes by Claims
Medicare claims nationally billed by providers whose primary NUCC taxonomy is this code, broken down by billing code. This is a narrower population than the NPI Registrations count above, which includes providers holding this code as a secondary specialty — the two sections are not directly comparable. Source: CMS Medicare Physician & Other Practitioner by Provider and Service data.
440 rows
| Code | Description | Avg Paid | Claims |
|---|---|---|---|
| J1100 | J1100 – Injection, dexamethasone sodium phosphate, 1 mg | $0 | 448.5K |
| 99214 | 99214 – The provider sees an established patient for an office visit or other outpatient visit invol… | $93 | 384.1K |
| J3301 | J3301 – Injection, triamcinolone acetonide, not otherwise specified, 10 mg | $1 | 268.3K |
| Q9966 | Q9966 – Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | $0 | 266.1K |
| 99213 | 99213 – The provider sees an established patient for an office visit or other outpatient visit invol… | $66 | 248.3K |
| J0585 | J0585 – Injection, onabotulinumtoxina, 1 unit | $5 | 205.8K |
| Q9967 | Q9967 – Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | $0 | 133.5K |
| J7328 | J7328 – Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | $1 | 111.7K |
| J7320 | J7320 – Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg | $5 | 98.8K |
| Q9965 | Q9965 – Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml | $1 | 97.8K |
Showing 1–10 of 440
Medicare: Top Providers by Revenue
The highest-revenue Medicare providers whose primary NUCC taxonomy is this code. This list can overlap with the Medicaid list below — a provider can rank highly in both programs.
Medicaid: Revenue by Year
Medicaid: Top Billing Codes by Claims
Medicaid claims billed by providers whose primary NUCC taxonomy is this code, broken down by state. This is a narrower population than the NPI Registrations count above, which includes providers holding this code as a secondary specialty — the two sections are not directly comparable. Source: state Medicaid claims data.
555 rows
| Code | Description | Avg Paid | Claims |
|---|---|---|---|
| 99214 | 99214 – The provider sees an established patient for an office visit or other outpatient visit invol… | $41 | 1.5M |
| 99213 | 99213 – The provider sees an established patient for an office visit or other outpatient visit invol… | $30 | 899.6K |
| 99308 | 99308 – The provider sees a patient for a subsequent nursing facility care visit involving evaluatio… | $17 | 367.8K |
| 80307 | 80307 – The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to sc… | $29 | 310.6K |
| 99309 | 99309 – The provider sees a patient for a subsequent nursing facility care visit involving evaluatio… | $20 | 294.2K |
| 80305 | 80305 – The lab analyst performs presumptive drug test(s) by any method that the analyst can read by… | $7 | 155.7K |
| G0483 | G0483 – Drug test(s), definitive, utilizing (1) drug identification methods able to identify individ… | $112 | 131.5K |
| 99000 | 99000 – Use this code for the in office preparation of a specimen for lab analysis and or its transp… | $2 | 117.5K |
| 97110 | 97110 – Therapeutic exercise is a form of physical therapy that utilizes specially designed exercise… | $22 | 116.6K |
| G8427 | G8427 – Eligible clinician attests to documenting in the medical record they obtained, updated, or r… | $0 | 104K |
Showing 1–10 of 555
Medicaid: Top Providers by Revenue
The highest-revenue Medicaid providers whose primary NUCC taxonomy is this code. This list can overlap with the Medicare list above — a provider can rank highly in both programs.
| Provider | State | Revenue |
|---|---|---|
| LAGS SPINE AND SPORTSCARE MEDICAL CENTERS INC | CA | $33.4M |
| NORCAL PAIN TREATMENT CENTER CORP | CA | $11.5M |
| MOUNTAIN VIEW PAIN SPECIALISTS | CO | $9.9M |
| VALLEY PAIN RELIEF AND WELLNESS CENTER, PLLC | MN | $9.2M |
| NOVUS PAIN MANAGEMENT - MARYLAND, LLC | MD | $6.4M |
| ADVANCED SPINE AND PAIN CENTER, P.A. | NC | $5.1M |
| COLORADO HEALTH PROVIDERS LLC | CO | $4.9M |
| PAIN SPECIALISTS OF CINCINNATI, LLC |
Frequently Asked Questions
References
- 1.NPI Registry. Centers for Medicare & Medicaid Services (CMS), National Plan and Provider Enumeration System (NPPES). Retrieved Aug 11, 2026.The public NPPES lookup tool for verifying a provider's National Provider Identifier, practice address, and taxonomy classification.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.